Literature DB >> 11112130

Gender-related differences in severe, early-onset chronic obstructive pulmonary disease.

E K Silverman1, S T Weiss, J M Drazen, H A Chapman, V Carey, E J Campbell, P Denish, R A Silverman, J C Celedon, J J Reilly, L C Ginns, F E Speizer.   

Abstract

Men have higher prevalence rates of chronic obstructive pulmonary disease (COPD) than women, which has been attributed to the historically higher rates of cigarette smoking in males. However, the increased rates of cigarette smoking in females within the last several decades have been associated with steadily increasing rates of COPD in women. As part of a study of the genetics of severe, early-onset COPD, we assembled a group of 84 probands with severe, early-onset COPD (without severe alpha(1)-antitrypsin deficiency) and 348 of their first-degree relatives. We found a markedly elevated prevalence (71.4%) of females among the early-onset COPD probands. Among the entire group of first-degree relatives of early-onset COPD probands, univariate analysis demonstrated similar spirometric values and bronchodilator responsiveness in males and females; however, among current or ex-smokers, female first-degree relatives had significantly lower FEV(1)/ FVC (81.4 +/- 17.2% in females versus 87.0 +/- 12.9% in males, p = 0.009) and significantly greater bronchodilator responsiveness (expressed as percentage of baseline FEV(1)) (7.7 +/- 9.4% pred in females versus 4.1 +/- 6.4% pred in males, p = 0.002). Female smoking first-degree relatives were significantly more likely to demonstrate profound reductions in FEV(1) (< 40% pred) than male smoking first-degree relatives (p = 0. 03). Multivariate analysis, performed with generalized estimating equations, demonstrated that current or ex-smoking female first-degree relatives had significantly greater risk of FEV(1) < 80% pred (OR 1.91, 95% CI 1.03- 3.54), FEV(1) < 40% pred (OR 3.56, 95% CI 1.08-11.71), and bronchodilator response greater than 10% of baseline FEV(1) (OR 4.74, 95% CI 1.91-11.75). These results suggest that women may be more susceptible to the development of severe COPD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112130     DOI: 10.1164/ajrccm.162.6.2003112

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  86 in total

1.  Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

Authors:  D L DeMeo; V J Carey; H A Chapman; J J Reilly; L C Ginns; F E Speizer; S T Weiss; E K Silverman
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

2.  Methylated Genes in Sputum Among Older Smokers With Asthma.

Authors:  Akshay Sood; Hans Petersen; Christopher M Blanchette; Paula Meek; Maria A Picchi; Steven A Belinsky; Yohannes Tesfaigzi
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

3.  Sex differences in the development of airway epithelial tolerance to naphthalene.

Authors:  K M Sutherland; P C Edwards; T J Combs; L S Van Winkle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

4.  Gender and chronic obstructive pulmonary disease: why it matters.

Authors:  Meilan K Han; Dirkje Postma; David M Mannino; Nicholas D Giardino; Sonia Buist; Jeffrey L Curtis; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

5.  Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.

Authors:  Craig P Hersh; Dawn L Demeo; Christoph Lange; Augusto A Litonjua; John J Reilly; David Kwiatkowski; Nan Laird; Jody S Sylvia; David Sparrow; Frank E Speizer; Scott T Weiss; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04-07       Impact factor: 6.914

6.  Influence of donor-recipient gender mismatch on graft function and survival following lung transplantation.

Authors:  Antonio Alvarez; Paula Moreno; Jennifer Illana; Dionisio Espinosa; Carlos Baamonde; Elisabet Arango; Francisco Javier Algar; Angel Salvatierra
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-15

Review 7.  Natural history of emphysema.

Authors:  Omar A Minai; Joshua Benditt; Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 8.  Treatment of chronic obstructive pulmonary disease in older patients: a practical guide.

Authors:  Abebaw M Yohannes; Christopher C Hardy
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.

Authors:  Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman
Journal:  Thorax       Date:  2013-03-23       Impact factor: 9.139

10.  Lifestyle and perceived health in subjects with chronic bronchitis or emphysema: a cross-sectional study.

Authors:  Dejana S Vukovic; Ljudmila M Nagorni-Obradovic; Goran M Vukovic
Journal:  BMC Public Health       Date:  2010-09-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.